BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/5/2026 9:17:05 AM | Browse: 7 | Download: 0
Publication Name World Journal of Psychiatry
Manuscript ID 127252
DOI 10.5498/wjp.127252
Country China
Category Psychology
Manuscript Type Review
Article Title Progress in research on the inflammatory and immunological mechanisms and interventions for the comorbidity of psoriasis and depression
Manuscript Source Unsolicited Manuscript
All Author List Yi-Ping Sun, Rui Yuan, Qiong Zhang and Su-Qing Yang
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82474505
Corresponding Author Su-Qing Yang, MD, Dermatology Department, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Dermatology Department,First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin,No.26, Heping Road, Xiangfang District, Harbin 150000, Heilongjiang Province, China. ysq_1964@163.com
Key Words Psoriasis; Psoriatic arthritis; Depression; Comorbidity; Inflammatory and immune mechanisms; Th17/IL-17 axis; Kynurenine pathway; Biologics
Core Tip Shared inflammatory and immune pathways are proposed to link psoriasis and depression, though the causal chain from peripheral inflammation to central symptoms remains incompletely validated in comorbid patients. IL-23/Th17-derived cytokines, hypothalamic-pituitary-adrenal axis dysregulation, kynurenine pathway shifts, central sensitization, impaired brain-derived neurotrophic factor signaling, and gut dysbiosis may converge on emotional regulation circuits. Biologics and small molecules target skin/joint inflammation; antidepressants and psychological interventions directly target depressive symptoms; lifestyle interventions reduce global burden. Evidence with formally diagnosed depression as a primary endpoint is still lacking.
Citation Sun YP, Yuan R, Zhang Q, Yang SQ. Progress in research on the inflammatory and immunological mechanisms and interventions for the comorbidity of psoriasis and depression. World J Psychiatry 2026; In press
PDF 127252-in-press.pdf
Received
2026-09-08 11:09
Peer-Review Started
2026-09-08 11:09
First Decision by Editorial Office Director
Return for Revision
2026-09-23 07:05
Revised
2026-09-30 06:10
Publication Fee Transferred
2026-10-30 03:52
Second Decision by Editor
2026-11-05 01:43
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-11-05 09:17
Articles in Press
2026-11-05 09:17
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3206 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com